For the Inventor, By the Inventor

Enter assignee name

Laboratorios Farmaceuticos Rovi S.a.

USPTO Granted Patents = 32

CIPO Patents = 3

EPO Patents = 17

Trademarks = 18

Forward Citations = 167

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Ibon Gutierro Aduriz (27 out of 30 patents)

Guillermo Franco Rodriguez (11 out of 11 patents)

Maria Teresa Gomez Ochoa (10 out of 11 patents)

4. Elena Cebadera Miranda (3 out of 4 patents)

5. Guillermo Franco Rodríguez (2 out of 3 patents)

6. Roland Bodmeier (2 out of 8 patents)

7. Maria Garcia Amo (2 out of 2 patents)

8. Ivan Lopez-Belmonte Encina (1 out of 2 patents)

9. Carlos Jose Albaladejo Jimenez (1 out of 1 patent)

10. Philippe Maincent (1 out of 4 patents)

11. Jean Sarkis Mardiguian (1 out of 1 patent)

12. Javier Martinez Gonzalez (1 out of 1 patent)

13. Iván López-Belmonte Encina (1 patent)

14. Nathalie Ubrich (1 patent)

15. Claude Vigneron (3 patents)

32 patents: Sort by Forward Citations

1. 12318478 - Risperidone or paliperidone implant formulation (2025-06-03),

2. 12318387 - Method of treating acute exacerbation of schizophrenia with long-acting injectable depot composition (2025-06-03),

3. 12226485 - Injectable composition (2025-02-18),

4. 11987410 - Procedure for the filling of solids in pharmaceutical containers and the sealing thereof under sterile conditions (2024-05-21),

5. 11918682 - Injectable composition with aromatase inhibitor (2024-03-05),

6. 11827391 - Process and equipment assembly for aseptic gravimetric filling of solids into a container (2023-11-28),

7. 11759416 - Antipsychotic injectable depot composition (2023-09-19),

8. 11752094 - Antipsychotic injectable depot composition (2023-09-12),

9. 11752093 - Antipsychotic injectable depot composition (2023-09-12),

10. 11752092 - Methods for the preparation of injectable depot compositions (2023-09-12),

11. D967414 - Syringe backstop (2022-10-18),

12. 11241377 - Antipsychotic injectable depot composition (2022-02-08),

13. 11173110 - Risperidone or paliperidone implant formulation (2021-11-16),

14. 11013683 - Paliperidone implant formulation (2021-05-25),

15. 11007139 - Risperidone or paliperidone implant formulation (2021-05-18),

LABORATORIOS FARMACEUTICOS ROVI S.A. is a Spanish pharmaceutical company engaged in the research, development, manufacturing, and commercialization of specialized medicines and active pharmaceutical ingredients. With a strong focus on innovation and quality, ROVI operates across various therapeutic areas including rare diseases, hospital products, and specialty pharmaceuticals. The company strives to improve patients' lives by offering advanced healthcare solutions and contributing to the development of new treatments.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

32 Patents

#11 in Madrid

#53 in Spain

#20,109 in the World

Laboratorios Farmaceuticos Rovi S.a.

Forward Citations = 167

12 inventors:

Ibon Gutierro Aduriz (27 out of 30 patents)

Guillermo Franco Rodriguez (11 out of 11 patents)

Maria Teresa Gomez Ochoa (10 out of 11 patents)

4. Elena Cebadera Miranda (3 out of 4 patents)

5. Guillermo Franco Rodríguez (2 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…